Preprint
Article
The Novel Thienopyrimidine Derivative, RP-010, Produces Its Efficacy in Prostate Cancer Cells by Inducing the Fragmentation of β-catenin
This version is not peer-reviewed.
Submitted:
01 March 2019
Posted:
04 March 2019
You are already at the latest version
A peer-reviewed article of this preprint also exists.
Abstract
Keywords:
Subject:
Medicine and Pharmacology - Oncology and Oncogenicssupplementary.pdf (2.28MB )
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Alerts
MDPI Initiatives
Important Links
© 2025 MDPI (Basel, Switzerland) unless otherwise stated